TY - JOUR
T1 - The Alopecia Areata Consensus of Experts (ACE) study part II
T2 - Results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata
AU - Meah, Nekma
AU - Wall, Dmitri
AU - York, Katherine
AU - Bhoyrul, Bevin
AU - Bokhari, Laita
AU - Asz-Sigall, Daniel
AU - Bergfeld, Wilma F.
AU - Betz, Regina C.
AU - Blume-Peytavi, Ulrike
AU - Callender, Valerie
AU - Chitreddy, Vijaya
AU - Combalia, Andrea
AU - Cotsarelis, George
AU - Craiglow, Brittany
AU - Donovan, Jeff
AU - Eisman, Samantha
AU - Farrant, Paul
AU - Green, Jack
AU - Grimalt, Ramon
AU - Harries, Matthew
AU - Hordinsky, Maria
AU - Irvine, Alan D.
AU - Itami, Satoshi
AU - Jolliffe, Victoria
AU - King, Brett
AU - Lee, Won Soo
AU - McMichael, Amy
AU - Messenger, Andrew
AU - Mirmirani, Paradi
AU - Olsen, Elise
AU - Orlow, Seth J.
AU - Piraccini, Bianca Maria
AU - Rakowska, Adriana
AU - Reygagne, Pascal
AU - Roberts, Janet L.
AU - Rudnicka, Lidia
AU - Shapiro, Jerry
AU - Sharma, Pooja
AU - Tosti, Antonella
AU - Vogt, Annika
AU - Wade, Martin
AU - Yip, Leona
AU - Zlotogorski, Abraham
AU - Sinclair, Rodney D.
N1 - Publisher Copyright:
© 2020 American Academy of Dermatology, Inc.
PY - 2021/6/1
Y1 - 2021/6/1
N2 - Background: We previously reported the Alopecia Areata Consensus of Experts study, which presented results of an international expert opinion on treatments for alopecia areata. Objective: To report the results of the Alopecia Areata Consensus of Experts international expert opinion on diagnosis and laboratory evaluation for alopecia areata. Methods: Fifty hair experts from 5 continents were invited to participate in a 3-round Delphi process. Consensus threshold was set at greater than or equal to 66%. Results: Of 148 questions, expert consensus was achieved in 82 (55%). Round 1 consensus was achieved in 10 of 148 questions (7%). Round 2 achieved consensus in 47 of 77 questions (61%). The final face-to-face achieved consensus in 25 of 32 questions (78%). Consensus was greatest for laboratory evaluation (12 of 14 questions [86%]), followed by diagnosis (11 of 14 questions [79%]) of alopecia areata. Overall, etiopathogenesis achieved the least category consensus (31 of 68 questions [46%]). Limitations: The study had low representation from Africa, South America, and Asia. Conclusion: There is expert consensus on aspects of epidemiology, etiopathogenesis, clinical features, diagnosis, laboratory evaluation, and prognostic indicators of alopecia areata. The study also highlights areas where future clinical research could be directed to address unresolved hypotheses in alopecia areata patient care.
AB - Background: We previously reported the Alopecia Areata Consensus of Experts study, which presented results of an international expert opinion on treatments for alopecia areata. Objective: To report the results of the Alopecia Areata Consensus of Experts international expert opinion on diagnosis and laboratory evaluation for alopecia areata. Methods: Fifty hair experts from 5 continents were invited to participate in a 3-round Delphi process. Consensus threshold was set at greater than or equal to 66%. Results: Of 148 questions, expert consensus was achieved in 82 (55%). Round 1 consensus was achieved in 10 of 148 questions (7%). Round 2 achieved consensus in 47 of 77 questions (61%). The final face-to-face achieved consensus in 25 of 32 questions (78%). Consensus was greatest for laboratory evaluation (12 of 14 questions [86%]), followed by diagnosis (11 of 14 questions [79%]) of alopecia areata. Overall, etiopathogenesis achieved the least category consensus (31 of 68 questions [46%]). Limitations: The study had low representation from Africa, South America, and Asia. Conclusion: There is expert consensus on aspects of epidemiology, etiopathogenesis, clinical features, diagnosis, laboratory evaluation, and prognostic indicators of alopecia areata. The study also highlights areas where future clinical research could be directed to address unresolved hypotheses in alopecia areata patient care.
KW - Delphi
KW - alopecia areata
KW - assessment
KW - consensus
KW - guideline
UR - https://www.scopus.com/pages/publications/85104358026
UR - https://www.scopus.com/inward/citedby.url?scp=85104358026&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2020.09.028
DO - 10.1016/j.jaad.2020.09.028
M3 - Article
C2 - 32926985
AN - SCOPUS:85104358026
SN - 0190-9622
VL - 84
SP - 1594
EP - 1601
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 6
ER -